Cell-Based Bioassay

    36
    Catalina Garcia
    by Catalina Garcia
    Published: January 23, 2025 (1 month ago)

    The detection of cell-based monoclonal antibody (mAb) therapies is an area in which Creative Biolabs has extensive experience. From basic first-level performance assessment to thorough evaluation of the biological activity of biobetter compounds, our scientific research team can help the creation, optimization, identification, and verification of important bioassays. Measurements of cell proliferation, cell death, immune effector function activation, biomarker expression, signaling event induction or inhibition, and antibody internalization techniques are among our areas of competence. To guarantee a comprehensive solution for your molecular characterisation, our specialists collaborate directly with you to deliver a completely confirmed efficacy test. Learn more: Cell-Based Bioassay